chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Given vaccines by fellow med student. Complained of left arm pain, right after TD given, IM in left acromion area and "hit bone". Noted headache a few hours after vaccine. Felt feverish at 23:00 and went to bed and noted neck and back pain. Woke during the night with a temperature of 101F. Temperature at 07:30 was 103.8F. Seen by ARNP and was advised rest, fluids, Tylenol alternated with Motrin. Dx'd with fever and possible vaccine reaction. Advised to go to ER if symptoms worsen. On 3/13/03, temperature resolved but arm is still sore.
Within one hour of the shot administration I became tachycardia, hypertensive, and with chills. Over the next 48 hours my symptoms worsened to include headaches, dizziness, fatigue, and near syncope requiring an emergent visit to the ER.  My symptoms persisted and two weeks  later I required another visit to the ER and was admitted to the hospital overnight due to tachycardia, hypertension, diarrhea, chest pressure, headaches, fatigue, weakness, chills, and near syncope.  Since the onset of events post the Pfizer vaccine, I have required multiple visits with MDs/specialist for management of symptoms and course of treatment.  My local physician suspected postural orthostatic tachycardia syndrome (POTS) of which I seeked medical opinion and met with a world expert and after meeting with him, he concluded my symptoms were in fact in line with POTS.  Since then I have continued to experience flare-ups and episodes of tachycardia, most recently 4/14/2021.  It has now been over 3 months since the onset of symptoms post vaccine and I continue to require treatment and management of above symptoms.  I have not returned back to previous level of function nor have I been able to return to work.  I do not have any prior medical history of this condition or set of symptoms.
HCP called regarding VARIVAX. Product had undergone TE and it was administered after the TE. No reported adverse reactions.; No reported adverse reactions; This spontaneous report has been received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On an unknown date, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (valid lot number W039294 [expiration date 11-DEC-2024]) (dose, dose number, frequency, route of administration, vaccination scheme, and anatomical location was not provided), after temperature excursion (product storage error).  No additional adverse event (AE).
Red, rash, 1.5 in cm in deiameter starting 24 hours after ADM.
Information has been received from an office manager concerning a female (age not reported) with a history of passing out when receiving shots who on an unspecified date was vaccinated with Gardasil (lot # not reported) 0.5 ml injection. On an unspecified date, the patient passed out after the shot of Gardasil, unknown which dose. Unspecified medical attention was sought. The patient recovered later in the day. Additional information has been requested. Follow-up information was received in which it was reported that no patient had a problem with this vaccine. We have been misinformed. No additional information is expected.
I became pregnant even though birth control is taken daily.  Had a miscarriage. Additionally, I had critically low blood sugar in November.
Moderate to severe ear ringing the day after dose 1.  The ringing has not stopped in four weeks and the left ear has worsened and feels clogged but no pain in either just a constant loud ringing.  Scheduled appt with ENT and said my ears were fine, slight hearing loss in left ear, and inflammation of my inner ear likely caused by the immune response to the vaccine which is causing the ringing.  Do not know if will go away short or long term, or ever.  Prescribed a heavy dose of prednisone over two week period.  After one week, the problem of ringing in my left ear remains at the same level and sometimes worse than previous.  I was recommended not to take the second dose as it could possibly amplify the issue even more.
Breakthrough COVID infection; Breakthrough COVID infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single and administration date May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "had COVID", start date: Nov2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "Breakthrough COVID infection". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) positive.  Clinical information: Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt vaccinated with Meruvax II developed pain & swelling of both shoulders & all joints of the hands & wrists.
(Please note I am making this report for a Pfizer bio tech vaccine that was done abroad, for the sole purpose of providing information for CDC)  I got my first vaccine on a Saturday. Three days later on a Tuesday I got four like symptoms. Whilst resting at home I wake up on Thursday with tachycardia (130bpm) Same the next day, and the end it seems to stop. About a week later I start noticing every time I get up my heart rate jumps to 120-130 bpm and stays there. Returning to normal resting heart  levels when sitting back down. Same thing happens now when just walking, it used to be no more than 100 after a 20 minute walk or so, but it stays at 120-130 now. A small uphill will send it to about 155bpm. Every morning now when I wake up, if I stand up it?s there at around 120-130. As the day goes by the resting heart rate seems to fall, and by the late afternoon usually it?s back to normal levels, maybe even bradycardic levels below 60bpm, without a feeling of fainting or anything. My pathologist in country who examined me was surprised by this as he confirmed the large range of heart rate from simple standing and sitting tests whilst checking blood pressure etc, pointing to a possible autonomic nervous system issue, maybe even POTS syndrome. Whilst I do have cardiomyopathy, this huge variation in heart rate started with the 1st vaccine whilst going through the typical side effects. I used to walk 6 miles a day for exercise only and then some depending on that day?s obligations. I also eat pretty healthily and am no overweight. I just wanted to let someone know for research purposes.
Moderna COVID-19 Vaccine EUA I had pain in shoulder at first, then the whole left arm sore then to the point I could not use it. The day after shot at 8:30 pm I was feeling fine. Then all of a sudden my face which is usually red turned pale white. My stomach got chills and started to sweat a lot. I could not keep my head up and was very close to passing out. My wife was scared to the point she almost called 911 for me.
ADMINISTRATION ERROR.     A 30 YEARS OLD FEMALE COMES TO THE CLINIC FOR HER BOSTER FOR PFIZER. AT THE MOMENT OF THE ADMINISTRATION THE NURSE DONT ESTIMATED THE TIME AND  SHE IMMUNIZED THE PATIENT BEFORE THE 6 MONTHS AS THE HEALTH DEPARTMENT RECOMMENDS.   PATIENT CALL TO THE CLINIC AT NOVEMBER 30,2021 BECAUSE SHE HAS HEADACHE AND TACHYCARDIA.
No adverse event; Patient was administered with Monovalent vaccine; This spontaneous case was reported by a medical assistant and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient was administered with Monovalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 6-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Apr-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Apr-2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient was administered with Monovalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient was administered with Monovalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient was administered with Monovalent vaccine).    It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-721452, US-MODERNATX, INC.-MOD-2023-721454 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-721452:Same reporter US-MODERNATX, INC.-MOD-2023-721454:Same reporter
ITCHING, HEAT AND SWELLING TO SITE.  INSTRUCTED TO APPLY ICE, TAKE BENADRY AND IF SHORTNESS OF AIR SYMPTOMS TO CALL 911 OR GO TO THE ER.
606 doses were given after expiration date; Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 08-Nov-2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 08-Nov-2021) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 08-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 08-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications was reported. No temperature excursion and adverse event was reported. Vials was placed in refrigerator on 08 Nov 2021.
Woke up that night with chills and numbness/tingling on right side. Went to the hospital and they found a DVT Blood Clot on my right collarbone. Two days later my left side started getting numb/tingling in my foot and hand.  1 week later and I still have numbness and tingling on both sides.
Very painful joints. Large joints hurt most. Pelvis, shoulders. Ankles and wrists are also painful
Pt developed mucousy and occasional blood tinged stools 2 to 6 times per day since vaccines given. Heme + stool noted in office on 9/6.
A physician reported the occurrence of an injection site reaction in a 19 month old male who was vaccinated with DTAP (Infanrix) for prophylaxis. The pt had no relevant medical history, concurrent conditions or concurrent medications. This pt had no adverse experiences following previous immunizations. On 05/12/03, the pt received the fourth injection of Infanrix (Lot # DTPA589A2). On the same date, he also received an injection of IPV.  On 05/14/03, two days post-immunization, the pt developed an injection site reaction characterized by redness and swelling at the site of Infanrix administration.  The pt was seen by the physician. The injection site reaction resolved on 05/19/03.  The reporting physician considered the injection site reaction to be related to Infanrix administration.
Pt recvd vax on 11JUL91 @ well pt clinic devel difficuly in walking lt leg on 27JUL which has resolved & now has developed a generalized rash, runny nose & afebrile; no other difficulties advised to call MD for eval;
pt recvd vax; excessive crying for more than 3 hrs, same day of vax;
Tachypnea, lung rales and dx'd with bronchiolitis and treated with oral prednisone and albuterol neb q 4 hrs. Child had fever, cough and sore throat beginning 1 wk after VARIVAX vaccination. Sibling had similar C/O's 1 wk after VARIVAX given @ same time as sister.
Myocarditis.  Developed severe headache (3 days) with chest pain (for 1 days). Noted to have high sensitivty troponin 6000 > 6000 > 8000.  ECHO WNL. CTA heart, WNL.
Redness to right arm began on the day after vaccination. Today if now day four and redness has spread to under arm with lymph node swelling in arm pit. No drainage.
Patient came into pharmacy day after immunization (11/16/17) to report that her arm had swollen and was hot to the touch approximately 5 hours after receiving the immunization. Patient took some ADVIL afterwards. Discussed with patient to see provider if worsens or could take some BENADRYL for symptom relief.
Information has been received from a 60 year old female patient with abnormal blood pressure and reactions/allergies to sulfa, LEVAQUIN and CT dye. On 10-MAR-2016, the patient was vaccinated with ZOSTAVAX in the left arm (1 time injection; dose, route, lot # and expiration date were not reported). The patient was also on unspecified concomitant medications "for blood pressure". On the same day, the patient experienced a red rash, "about the size of a fifty cent piece" at the insertion site, and "it was bruised in the middle". She also stated having "headaches, nausea, itchiness at the site, and heart palpitations", after getting the vaccine. The patient did not seek medical attention. Outcome of the event was not reported. Causality assessment was not reported. Additional information is not expected as the physician is not allowed to be contacted.
Expired vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial was initially stored in the refrigerator on 04-Apr-2022. It was reported that the vial had not underwent any temperature excursion.  No treatment medications were reported.
No adverse rx or events reported by patient at this time.  Pt has been seen by outside medical providers since time of administration.  Review of office notes in care everywhere does not indicate any complaints of adverse rx or event.
The night of the vaccinations, the site was extremely swollen and red.  By the following evening it had turned warm to the touch and had what looked like hives. The redness had also spread. I took her to the ER where the doctor concluded she had an infection at her vaccination injection site.
Information has been received from a pharmacist referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with an unspecified number of doses of improperly stored ZOSTAVAX (lot # M042504 with expiration date of 30-NOV-2017, lot# N011366 with expiration date of 12-MAR-2018; dosage, frequency and route unspecified) for prophylaxis with sterile diluent (lot# M034443 with expiration date of 20-APR-2019). No adverse effects were reported. It was reported that the temperature was from -14 to -10 degree C and tie frame was 3 hours. There was no previous temperature excursion.
Patient received vaccine 8/12/2021. Beginning 8/16/2021, he experienced SOB and was not able to walk comfortably, even for short distances. He contacted doctor on 8/19 or 8/20/2021. Discovered blood clots throughout his entire body. Hospitalized from 8/27 to 8/31/2021. Released on blood thinner; however, patient is unable to say which medication.
Potentially COPD after 2nd dose; Started to get a cough after 2nd dose/Worsening cough after 2nd dose; Emphysema after 2nd dose; Started hurting under his right rib cage when he sneezed/pain under his right rib cage got stronger; Fever for 2-3 hours the day after 2nd dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Potentially COPD after 2nd dose), COUGH (Started to get a cough after 2nd dose/Worsening cough after 2nd dose), EMPHYSEMA (Emphysema after 2nd dose), MUSCULOSKELETAL CHEST PAIN (Started hurting under his right rib cage when he sneezed/pain under his right rib cage got stronger) and PYREXIA (Fever for 2-3 hours the day after 2nd dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045b21a and 018b21a) for COVID-19 vaccination.     No medical history provided by reporter.  Concomitant products included DOXYCYCLINE and IBUPROFEN for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Potentially COPD after 2nd dose), COUGH (Started to get a cough after 2nd dose/Worsening cough after 2nd dose), EMPHYSEMA (Emphysema after 2nd dose), MUSCULOSKELETAL CHEST PAIN (Started hurting under his right rib cage when he sneezed/pain under his right rib cage got stronger) and PYREXIA (Fever for 2-3 hours the day after 2nd dose). At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Potentially COPD after 2nd dose), COUGH (Started to get a cough after 2nd dose/Worsening cough after 2nd dose), EMPHYSEMA (Emphysema after 2nd dose), MUSCULOSKELETAL CHEST PAIN (Started hurting under his right rib cage when he sneezed/pain under his right rib cage got stronger) and PYREXIA (Fever for 2-3 hours the day after 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: abnormal (abnormal) detected emphysema and potentially COPD..         Action taken with mRNA-1273 in response to the drug was not applicable. No treatment information reported.   This case was linked to MOD-2021-103566 (Patient Link).
Left shoulder/upper arm pain persisting 3 weeks after injection with limited shoulder range of motion.
12:12 Patient is in the Observation Area post VAccination on her LEft Arm 2nd dose, suddenly complaints of dizziness, lightheadedness, clammy, pale  and cold skin. Vitals were taken as follows: 77/40,  HR 68, Oxygen SAturation 93%, Temp 97.  Kept attended,  both parents are with this 16 years old lady. Patient remained alert and oriented.    When Emergency TEam came and evaluate the patient, BP was 103/66, HR 84,  O2 saturation 95% and felt better.  Patient was advised to go to the emergency room for further evualtion but declined. EMS team left
Itchy bumps all over random areas on the body (back, arms, legs, torso, etc.) Started developing bumps 4 hours after getting the shot. Started developing the itchiness 8 hours after getting the shot.
EMPLOYEE REPORTED MIGRAINE STARTING 12/3/2022 IN THE MORNING WHEN SHE AWOKE. CONTINUED INTO SUNDAY, AND STARTED A FEVER SUNDAY AFTERNOON, TEMPERATURE  TAKEN ON 12/4/2022 AT 1600. AT THAT TIME 103.9, EMPLOYEE TOOK TYLENOL 500 MG X 2. THEN FEVER 105.0 1620, AND AT 1640 WAS 104.5, EMPLOYEE WENT TO BED. MORNING OF 12/5/2022 99.0. TEMPERATURE 12/5/2022 IN THE OFFICE AT 1138 98.1. HAS NO HEADACHE AT THIS TIME. DOES REPORT A RUNNY NOSE AT THIS TIME.
This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 55-year-old male patient who received SHINGRIX for prophylaxis. On 19th July 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 23rd July 2018, 4 days after receiving SHINGRIX, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was not recovered/not resolved. It was unknown if the reporter considered the injection site rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX left arm. The patient experienced a rash at the injection site about 1-2 inch in diameter. After 8 days post vaccination the rash was now 4 inches in diameter. The reporter gave permission to contact his health care provider. No further details were provided.
Information has been received from a physician concerning a 15 month old male who on 1/28/90 was vaccinated with a dose of MMRII. On 2/7/92, the pt developed a rash. The pt sought unspecified medical attention. Additional info has been requested.  Received on 06/04/2003: "Follow-up information received from the physician stated that he consulted an Immunologist who did not feel there was a "problem."  He also noted that the patient may receive another dose of the vaccine "this summer".  No further information is available.
Information has been received from a physician concerning a female (age not reported) who in February 2007, was vaccinated with a first dose of Gardasil. On 19-APR-2007, the patient was vaccinated intramuscularly with a 0.5 mL second dose of Gardasil. During the first dose of post vaccination with Gardasil, the patient developed a low grade fever (measurements not reported), nausea and vomiting. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. Additional information has been requested.
Almost immediately, she felt light headed and put her head between her legs.  She then leaned back and her eyes rolled back in her head and she slumped over to the right.  She was unresponsive and began wheezing/gasping for air, along with a few sneezes.  Someone called EMS and I gave her an Epipen in her right leg.  Within a few seconds, she became responsive and was dizzy and shaking.  The EMT arrived and checked her over.  She was able to stand and opted to go home, instead of the hospital.
my arm was sore at the injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (my arm was sore at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No treatment information provided.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (my arm was sore at the injection site). At the time of the report, VACCINATION SITE PAIN (my arm was sore at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information provided.   This case was linked to MOD-2021-071082 (Linked Report).; Sender's Comments:  MOD-2021-071082:Second dose of vaccine case
Swollen (R) thigh that is related likely to vaccine DTaP or IPV - Treated with Benadryl